Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.76 USD 1.47% Market Closed
Market Cap: 815.2m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Receivables
$64.4m
CAGR 3-Years
-33%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Receivables
CA$1.5m
CAGR 3-Years
-18%
CAGR 5-Years
74%
CAGR 10-Years
54%
Replicel Life Sciences Inc
XTSX:RP
Total Receivables
CA$103.8k
CAGR 3-Years
21%
CAGR 5-Years
48%
CAGR 10-Years
18%
Innovotech Inc
XTSX:IOT
Total Receivables
CA$204.8k
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
9%
No Stocks Found

Abcellera Biologics Inc
Glance View

Market Cap
802.7m USD
Industry
Life Sciences Tools & Services

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
1.67 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is Abcellera Biologics Inc's Total Receivables?
Total Receivables
64.4m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Receivables amounts to 64.4m USD.

What is Abcellera Biologics Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
78%

Over the last year, the Total Receivables growth was -38%. The average annual Total Receivables growth rates for Abcellera Biologics Inc have been -33% over the past three years , 78% over the past five years .

Back to Top